Natural Gum Or Resin Patents (Class 514/782)
  • Patent number: 9480691
    Abstract: A liquid medicament for use on skin, epithelium, epidermis, body surface and so on containing a refined peanut oil and, for example, at least one agent which minimizes cell growth, inflammation or both.
    Type: Grant
    Filed: February 29, 2012
    Date of Patent: November 1, 2016
    Assignee: Hill Dermaceuticals, Inc.
    Inventor: Jerry Roth
  • Publication number: 20150140084
    Abstract: The present disclosure relates to acid resistant banding solutions for two piece hard capsules, and methods of making the same. The present disclosure also relates, in part, to a method for banding such capsules which provides an acid resistant seal between the capsule parts and achieves an increased acid resistance in vitro. The instant disclosure further relates to a capsule sealing solution formula that comprises shellac ink or shellac ink vehicle component.
    Type: Application
    Filed: May 20, 2013
    Publication date: May 21, 2015
    Applicant: Capsugel Belgium NV
    Inventor: Takahisa Takubo
  • Publication number: 20150132346
    Abstract: A macroparticle pigment powder and methods of making the same. The macroparticle pigment powder comprises a plurality of macroparticle particles. The macroparticles are comprised of a matrix material that include pigment particles. In some embodiments the matrix material is polymeric in nature and selected from the group consisting of a natural latex, acrylics, polyacrylate, polymethacrylate, polyurethane, polyvinyl acetate, styrene-butadiene rubber, acrylonitrile butadiene styrene copolymer, and combinations thereof.
    Type: Application
    Filed: May 19, 2014
    Publication date: May 14, 2015
    Inventors: Yun Shao, Pascal Delrieu, David Schlossman, Frank Mazzella
  • Patent number: 8999961
    Abstract: Disclosed in certain embodiments is a controlled release oral dosage form comprising a therapeutically effective amount of a drug susceptible to abuse together with one or more pharmaceutically acceptable excipients; the dosage form further including a gelling agent in an effective amount to impart a viscosity unsuitable for administration selected from the group consisting of parenteral and nasal administration to a solubilized mixture formed when the dosage form is crushed and mixed with from about 0.5 to about 10 ml of an aqueous liquid; the dosage form providing a therapeutic effect for at least about 12 hours when orally administered to a human patient.
    Type: Grant
    Filed: July 19, 2013
    Date of Patent: April 7, 2015
    Assignees: Purdue Pharma, L.P., The P.F. Laboratories, Inc., Purdue Pharmaceuticals L.P.
    Inventors: Curtis Wright, Benjamin Oshlack, Christopher Breder
  • Patent number: 8906881
    Abstract: Chitosan-based nail formulations are useful to treat nail inflammatory diseases like psoriasis, atopic dermatitis and lichen planus. The chitosan is normally in the form of an amino-polysaccharide derivative, preferably water soluble, such as hydroxypropyl chitosan. The formulation may be a nail lacquer, a spray, a cream, an ointment, a gel, a lotion or a foam and may have a content in chitosan, chitosan derivative or a salt thereof from 0.1 to 25 wt. % with respect to the total weight of the formulation.
    Type: Grant
    Filed: February 7, 2008
    Date of Patent: December 9, 2014
    Assignee: Polichem SA
    Inventor: Federico Mailland
  • Patent number: 8894978
    Abstract: A new skin care system includes day and night skin cream compositions comprising nutrients and antioxidants for use by children between six months and eighteen years of age. The day skin cream composition provides protection from UV radiation and the night skin cream composition contains no sun protection ingredients and elevated levels of nutrients and antioxidants. A child-friendly bottle for each composition can be used by young children without difficulty. A fragrance included in each composition is popular with children, and the bottle for the day composition has graphics indicating day-time use and the bottle for the night composition has graphics indicating night-time use. The day composition is applied topically each day to the face after tooth-brushing, and the night composition is applied topically to the face each night after tooth-brushing.
    Type: Grant
    Filed: April 25, 2014
    Date of Patent: November 25, 2014
    Inventor: William Scott Prendergast
  • Patent number: 8883221
    Abstract: Micronutrient combination product, wherein the micronutrient combination product comprises zeaxanthin, lutein, zinc and copper.
    Type: Grant
    Filed: December 17, 2004
    Date of Patent: November 11, 2014
    Assignee: Bausch & Lomb Incorporated
    Inventors: Guenter Bellmann, Gudrun Claus-Herz
  • Publication number: 20140294787
    Abstract: Nutritional products having improved cohesiveness of food boluses and methods of making and using same are provided. The nutritional products may include nutritional compositions and high molecular weight, water-soluble polymers such that the nutritional products have extensional viscosities that provide improved cohesiveness to the nutritional products and Trouton ratios of at least 6. Methods of administering such nutritional products to patients having impaired swallowing ability and/or dysphagia are also provided.
    Type: Application
    Filed: March 1, 2012
    Publication date: October 2, 2014
    Inventors: Adam Stewart Burbidge, Jan Engmann, Simina Popa Nita
  • Publication number: 20140287061
    Abstract: A biocompatible polymeric composition for cross-linking in-situ in a wound is disclosed comprising 1) one or more polyanionic polymers such as alginates or hyaluronates, able to be cross-linked the surface of the wound and 2) one or more polycationic polymers such as chitosan or DEAE-Dextran, that assists in the solidification process as well as speeds up hemostasis without the need for applying pressure. The biocompatible polymeric composition may further comprise a cross-linking agent such as aqueous calcium chloride. The invention encompasses an initial polymeric composition, the solidified matrix cross-linked and integrated at the wound site, including the methods of using, applying, and cross-linking the composition.
    Type: Application
    Filed: November 12, 2012
    Publication date: September 25, 2014
    Applicant: Suneris, Inc.
    Inventor: Joseph A. Landolina
  • Patent number: 8779006
    Abstract: The present invention is in the fields of medicine, pharmaceuticals, neutraceuticals and rheumatology. The invention provides pharmaceutical compositions for the treatment and/or prevention of osteoarthritis in mammals, particularly humans, comprising sodium bicarbonate and calcium gluconate, and optionally comprising one or more additional components. The invention also provides methods of treating or preventing osteoarthritis by administering to a mammal, preferably via intraarticular injection, one or more compositions of the invention.
    Type: Grant
    Filed: September 16, 2011
    Date of Patent: July 15, 2014
    Assignee: Nucitec S.A. de C.V.
    Inventors: Ricardo Amador, Jorge L. Rosado, Sandra García-Padilla, Miguel Ángel Duarte-Vázquez
  • Patent number: 8747817
    Abstract: A new skin care system includes day and night skin cream compositions comprising nutrients and antioxidants for use by children between six months and eighteen years of age. The day skin cream composition provides protection from UV radiation and the night skin cream composition contains no sun protection ingredients and elevated levels of nutrients and antioxidants. A child-friendly bottle for each composition can be used by young children without difficulty. A fragrance included in each composition is popular with children, and the bottle for the day composition has graphics indicating day-time use and the bottle for the night composition has graphics indicating night-time use. The day composition is applied topically each day to the face after tooth-brushing, and the night composition is applied topically to the face each night after tooth-brushing.
    Type: Grant
    Filed: December 2, 2011
    Date of Patent: June 10, 2014
    Inventor: William Scott Prendergast
  • Patent number: 8728524
    Abstract: New biomaterials consisting of a combination of sulphated hyaluronic acid and gellan (as well as gellan that has not been associated with other polymers), to be used as a highly effective barrier to prevent post-surgical adhesions in abdominal, pelvic and, above all, spine surgery.
    Type: Grant
    Filed: May 10, 2012
    Date of Patent: May 20, 2014
    Assignee: Anika Therapeutics S.R.L.
    Inventors: Davide Bellini, Cristina Longinotti, Vittorio Crescenzi, Anna Taglienti
  • Publication number: 20140127150
    Abstract: An inverse latex including from 20% to 70% by weight and preferably from 25% to 50% by weight of a branched or crosslinked polyelectrolyte, characterized in that the polyelectrolyte is a copolymer of 2-acrylamido-2-methylpropanesulfonic acid partially or totally salified with acrylamide and optionally one or more monomers chosen from monomers containing a partially or totally salified weak acid function and/or from neutral monomers other than acrylamide, the production process including the control of the pH in the initial aqueous phase; Cosmetic, dermopharmaceutical or pharmaceutical composition including the inverse latex directly obtained by the process.
    Type: Application
    Filed: January 13, 2014
    Publication date: May 8, 2014
    Applicants: Scott Bader Company Limited, Societe D'Exploitation De Produits Pour Les Industries Chimiques Seppic
    Inventors: Olivier BRAUN, Paul MALLO, Audrey BONNARDEL, Francois GUY
  • Patent number: 8703195
    Abstract: Disclosed is a method in which poloxamer, a resin, and/or a tocopherol is/are fused, and the material that is to be treated is intimately dispersed with said melt. After being introduced into the melt, the material that is to be treated is coated with water to prevent hardening, and the spontaneously forming gel is homogenized. The obtained product is composed of a transparent gel that is based on at least one poloxamer, a resin or a tocopherol, and an active substance which is solubilized, dispersed, and stabilized therein and whose consistency ranges from solid, semisolid, i.e. aspic-like, to liquid. The micelles of said solubilized matter remain stable even when the same is diluted well below the CMC of poloxamer.
    Type: Grant
    Filed: March 9, 2007
    Date of Patent: April 22, 2014
    Assignee: Biorem AG
    Inventor: Hanspeter Strobel
  • Patent number: 8680161
    Abstract: The present invention relates to compositions containing plant gums and one or more fat-soluble active ingredients, wherein the composition comprises less than 40 weight-% oil, based on the total composition in dry matter. These compositions can be used for the enrichment, fortification and/or coloration of food beverages, animal feed, cosmetics or pharmaceutical compositions. The present invention also refers to the preparation of such compositions. The present invention furthermore refers to a process for the manufacture of a beverage by mixing the compositions with ingredients of beverages. The present invention also refers to beverages obtainable by this process.
    Type: Grant
    Filed: June 3, 2009
    Date of Patent: March 25, 2014
    Assignee: DSM IP Assets B.V.
    Inventors: Andrea Hitzfeld, Bruno H. Leuenberger, Olivia Vidoni
  • Publication number: 20140044787
    Abstract: The present application discloses a sustained release composition in pellet form, wherein the core of the pellet comprises: (a) a therapeutically effective amount of a medicament; (b) 0.5 to 50% by weight of a water-soluble polymer; and (c) 1 to 25% by weight of a water-insoluble polymer applied as an aqueous latex dispersion and subsequently the water is removed, wherein the sum of the percentages of the medicament, the water-insoluble polymer and the water-soluble polymer is equal to or less than 100%. It also discloses methods of making this composition.
    Type: Application
    Filed: October 18, 2013
    Publication date: February 13, 2014
    Applicant: NOSTRUM PHARMACEUTICALS, LLC
    Inventor: Nirmal MULYE
  • Patent number: 8632813
    Abstract: Compositions and methods for the treatment of vasospasm are provided comprising applying an amount of a semi-solid vasoactive prostaglandin composition to the affected tissue. Also provided are methods of improving microcirculation in a replanted body part.
    Type: Grant
    Filed: October 19, 2007
    Date of Patent: January 21, 2014
    Assignee: Nexmed (Holdings), Inc.
    Inventors: Tian Wen, Liu Liu, Mingqi Lu, Jieshan Bai, Y. Joseph Mo
  • Publication number: 20130312970
    Abstract: An aqueous fluid contains an aqueous solution or dispersion of a polymer to thicken the fluid together with a cross linking agent to enhance the viscosity of the fluid by crosslinking the polymer, wherein the crosslinking agent comprises supporting structures bearing functional groups to react with the polymer molecules and has a mean particle size of 2 nanometer or more. The supporting structures may be nanoparticles and the functional groups may be boronic acid groups. The concentration of boron in a thickened fluid may be low and in some instances there is resistance to applied pressure. The fluid may be a hydraulic fracturing fluid.
    Type: Application
    Filed: November 22, 2011
    Publication date: November 28, 2013
    Applicant: SCHLUMBERGER TECHNOLOGY CORPORATION
    Inventors: Valerie Lafitte, Laetitia Corde, Laurent Pirolli, Gary John Tustin, Bruno Drochon
  • Publication number: 20130303494
    Abstract: Disclosed in certain embodiments is a controlled release oral dosage form comprising a therapeutically effective amount of a drug susceptible to abuse together with one or more pharmaceutically acceptable excipients; the dosage form further including a gelling agent in an effective amount to impart a viscosity unsuitable for administration selected from the group consisting of parenteral and nasal administration to a solubilized mixture formed when the dosage form is crushed and mixed with from about 0.5 to about 10 ml of an aqueous liquid; the dosage form providing a therapeutic effect for at least about 12 hours when orally administered to a human patient.
    Type: Application
    Filed: July 19, 2013
    Publication date: November 14, 2013
    Applicants: PURDUE PHARMACEUTICALS L.P., THE P.F. LABORATORIES
    Inventors: Curtis Wright, Benjamin Oshlack, Christopher Breder
  • Publication number: 20130281550
    Abstract: The present invention relates to compositions comprising octenyl-succinic anhydride-modified gum acacia and carotenoids. It has been found that the compositions according to the invention allow to produce emulsions having a very high color intensity, and color stability with a low turbidity. These compositions can be used for the enrichment, fortification and/or coloration of food beverages, animal feed, cosmetics or pharmaceutical compositions. The present invention furthermore refers to a process for the manufacture of a beverage by mixing the compositions with ingredients of beverages. The present invention also refers to beverages obtainable by this process.
    Type: Application
    Filed: October 4, 2011
    Publication date: October 24, 2013
    Applicant: DSM IP ASSETS B.V.
    Inventors: Andrea Hitzfeld, Bruno H. Leuenberger, Olivia Vidoni
  • Patent number: 8563039
    Abstract: New biomaterials consisting of a combination of sulphated hyaluronic acid and gellan (as well as gellan that has not been associated with other polymers), to be used as a highly effective barrier to prevent post-surgical adhesions in abdominal, pelvic and, above all, spine surgery.
    Type: Grant
    Filed: October 3, 2005
    Date of Patent: October 22, 2013
    Assignee: Anika Therapeutics S.R.L.
    Inventors: Davide Bellini, Cristina Longinotti, Vittorio Crescenzi, Anna Taglienti
  • Patent number: 8557871
    Abstract: Dermatological compositions containing, in a physiologically acceptable medium, at least one retinoid, dispersed benzoyl peroxide and at least one gelling agent of the family of the carrageenans, are useful for treating dermatological conditions and afflictions linked to disorders of cell differentiation and/or proliferation and/or keratinization, notably for treating acne vulgaris.
    Type: Grant
    Filed: July 9, 2010
    Date of Patent: October 15, 2013
    Assignee: Galderma Research & Development
    Inventors: Fabienne Louis, Sandrine Segura, Nathalie Willcox
  • Publication number: 20130251644
    Abstract: Described herein are cyclodextrin-stabilized microemulsion systems useful for increasing the solubility, stability, bioavailability, or safety of an active agent for delivery to the skin. The microemulsions may reduce the occurrence of skin irritation or odor upon application. In certain embodiments, the active agent is substantially insoluble in water. The microemulsions may be formulated as semi-solids, for example creams, or as aerosol or non-aerosol foams. Also described are methods of treating skin disorders, comprising the step of applying to an affected area of a subject in need thereof a therapeutically-effective amount of an inventive microemulsion.
    Type: Application
    Filed: March 14, 2013
    Publication date: September 26, 2013
    Applicant: Precision Dermatology, Inc.
    Inventors: Pinaki Ranjan Majhi, Mark W. Trumbore
  • Patent number: 8501822
    Abstract: An ophthalmic composition that, despite containing alginic acid and/or a salt thereof, has improved tackiness during use and provides a satisfactory use feeling. The composition has an improved ability to remain on the eye mucosa. The ophthalmic composition contains (A) alginic acid and/or a salt thereof in combination with (B) hyaluronic acid and/or a salt thereof.
    Type: Grant
    Filed: March 27, 2012
    Date of Patent: August 6, 2013
    Assignee: Rohto Pharmaceutical Co., Ltd.
    Inventors: Eri Matsumoto, Yasuko Nishina, Kenichi Haruna, Harumasa Arita, Akiko Kita
  • Patent number: 8501218
    Abstract: An edible chew pill jacket receives a pill/tablet or capsule that is to be administered to a pet, animal or human. The edible chew pill jacket includes a flexible top wall, side walls and bottom wall configured to form a chamber appointed to receive a pill. A flexible longitudinal slit is integrated within the top wall for providing access to the chamber for insertion of the pill within the edible chew pill jacket. The edible chew pill jacket is formulated with at least one flavoring to provide a tasty treat appointed to mask the pill's taste. The chew pill jacket substantially encapsulates the pill/tablet appointed to be orally ingested. The chew pill jacket may include medicament therein, nutrients, vitamins, or may simply be provided as a tasty treat to mask the taste of the pill.
    Type: Grant
    Filed: October 16, 2009
    Date of Patent: August 6, 2013
    Assignee: I Did It, Inc
    Inventor: Marni Markell Hurwitz
  • Publication number: 20130195769
    Abstract: The invention relates to stable oleaginous cosmetic or therapeutic foam compositions containing certain active agents, having unique therapeutic properties and methods of treatment using such compositions. The foamable composition includes at least one solvent selected from a hydrophobic solvent, a silicone oil, an emollient, a co-solvent, and mixtures thereof, wherein the solvent is present at a concentration of about 70% to about 96.5% by weight of the total composition, at least a non-ionic surface-active agent at a concentration of about 0.1% to less than about 10% by weight of the total composition; at least one gelling agent at a concentration of about 0.1% to about 5% by weight of the total composition; a therapeutically effective amount of at least one active agent; and at least one liquefied or compressed gas propellant, at a concentration of about 3% to about 25% by weight of the total composition.
    Type: Application
    Filed: March 11, 2013
    Publication date: August 1, 2013
    Applicant: FOAMIX LTD.
    Inventor: Foamix Ltd.
  • Patent number: 8475840
    Abstract: The sustained release formulation for oral administration of an HMG-CoA reductase inhibitor of the present invention can be easily and economically prepared and is capable of maintaining a constant drug level in blood by slowly releasing the HMG-CoA reductase inhibitor at a uniform rate for 24 hrs. Accordingly, the sustained release formulation of the present invention can be effectively used for lowering blood cholesterol and triglyceride levels.
    Type: Grant
    Filed: April 8, 2005
    Date of Patent: July 2, 2013
    Assignee: Hanmi Science Co., Ltd
    Inventors: Jong Soo Woo, Hong-Gi Yi, Moon-Hyuk Chi, Jae-Kuk Ryu, Si-Young Jung, Yong-Il Kim
  • Publication number: 20130164361
    Abstract: Formulations of pesticides are disclosed, specifically pesticidal blends of essential oils and other ingredients, that have been found to enhance the activity of the active pesticidal ingredients. The formulations may be, for example, emulsions or dust formulations. For example, a composition for controlling a target pest is disclosed that comprises at least one active agent and a formulation agent, wherein: the active agent is capable of interacting with a receptor in the target pest; the active agent has a first activity against the target pest when applied without the formulation agent and the composition has as a second activity against the target pest; and the second activity is greater than the first activity.
    Type: Application
    Filed: March 29, 2010
    Publication date: June 27, 2013
    Applicant: TYRATECH, INC
    Inventor: Essam Enan
  • Patent number: 8450311
    Abstract: Pharmaceutical compositions containing a fluoroquinolone antibiotic drug are disclosed. The compositions exhibit improved homogeneity, improved bioavailability, lower turbidity or a combination thereof. The composition can be use as otic or nasal compositions, but are particularly useful as ophthalmic compositions.
    Type: Grant
    Filed: May 29, 2009
    Date of Patent: May 28, 2013
    Assignee: Novartis AG
    Inventors: Inmaculada Campins, Nuria Jiménez, Roman Vidal, Nuria Carreras, Carmen Martinez, Francisco Javier Galán
  • Publication number: 20130115268
    Abstract: Methods for administering a dermatological agent to a subject are provided. In the subject methods an effective amount of a topical formulation of the dermatological agent is topically applied to a host. The topically applied formulation of dermatological agent is then occluded with a hydrogel patch, where a feature of the hydrogel patch is that it lacks a pharmaceutically active agent. Also provided are methods of treating a subject for a disease condition by administering a dermatological agent to the subject. Also provided are kits for use in practicing the subject methods. The subject methods and compositions find use in a variety of different applications.
    Type: Application
    Filed: December 27, 2012
    Publication date: May 9, 2013
    Applicants: TEIKIKOKU SEIYAKU KABUSHIKI KAISHA, TEIKOKU PHARMA USA, INC.
    Inventors: Teikoku Pharma USA, INC., Teikikoku Seiyaku Kabushiki Kaisha
  • Patent number: 8409598
    Abstract: It is an object of the present invention to provide a copper ion-producing composition that has a copper ion (mineral)-based germicidal activity against Legionella spp., Escherichia coli, Staphylococcus aureus, and saprophytic bacteria occurring in the water in drinking water storage tanks, hot springs, bathhouses, and pools, and that can supply mineral, and also to provide a granular composition that contains this copper ion-producing composition. The copper ion-producing composition is obtained by mixing 0.3 to 10 weight parts surfactant with 100 weight parts metallic copper powder. The granular composition is obtained by kneading this copper ion-producing composition with poorly water-soluble material that has a softening point of not less than 70° C. The granular composition is also obtained by coating the copper ion-producing composition on the surface of poorly water-soluble material that has a softening point of not less than 70° C.
    Type: Grant
    Filed: March 10, 2006
    Date of Patent: April 2, 2013
    Inventor: Iwao Hishida
  • Publication number: 20130065866
    Abstract: The present invention is a dentinal drug delivery composition composed of cationic and/or neutral porous particles containing an effective amount of a therapeutic agent, a method for using the dentinal drug delivery to provide a dental treatment, and a method for identifying anti-inflammatory agents capable of diffusing through dentin.
    Type: Application
    Filed: November 7, 2012
    Publication date: March 14, 2013
    Applicant: UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY
    Inventor: University of Medicine and Dentistry of New Jersey
  • Patent number: 8377470
    Abstract: A non-gelatin encapsulation system for liquid filled soft capsules, by nature of the carrier, the cationic-ionic balance of the carrier and the active ingredients, or the concentration of the active ingredients and excipients, are difficult or impossible to commercially encapsulate in gelatin capsules. In particular, the system is adapted for the encapsulation of highly basic, or alkaline, fills. The system provides for a predominantly starch and gelling carrageenan based shell, which displays high resistance to both concentrated fills and to alkaline fills, in particular, to those fills which contain the salt or salts of weak acids and strong bases.
    Type: Grant
    Filed: July 6, 2012
    Date of Patent: February 19, 2013
    Assignee: R.P. Scherer Technologies, LLC
    Inventors: Keith E. Tanner, Rickey S. Shelley, Norman S. Stroud, Elizabeth Youngblood
  • Publication number: 20120329790
    Abstract: The present invention is a dentinal drug delivery composition composed of cationic and/or neutral porous particles containing an effective amount of a therapeutic agent and a method for using the same to provide a dental treatment.
    Type: Application
    Filed: November 23, 2010
    Publication date: December 27, 2012
    Applicant: University of Medicine and Dentistry of New Jersey
    Inventor: Kenneth Markowitz
  • Publication number: 20120288566
    Abstract: The present invention discloses liquid precursor compositions adapted for application on a hard surface in the oral cavity, comprising at least one therapeutic agent suitable for the treatment of oral disorders, at least one acidic-pH sensitive polymer, at least one hydrophobic polymer, and a pharmaceutically acceptable volatile carrier, wherein a weight ratio between said at least one hydrophobic polymer and said at least one acidic-pH sensitive polymer is larger than 1. The invention also discloses formulations formed of the solidification of these compositions, and methods for treating oral disorders by applying these compositions on hard surfaces in the oral cavity or to be placed in the oral cavity.
    Type: Application
    Filed: October 5, 2010
    Publication date: November 15, 2012
    Applicant: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
    Inventors: Michael Friedman, Doron Steinberg, Irith Gati
  • Publication number: 20120288562
    Abstract: The present invention relates to new acid resistant hard pharmaceutical capsules, a process for their manufacture and use of such capsules particularly but not exclusively for oral administration of pharmaceuticals, veterinary products, food and dietary supplements to humans or animals. The capsules of the invention are obtained by aqueous compositions comprising a water soluble film forming polymer and gellan gum in a mutual weight ratio of 4 to 15 weight parts of gellan gum for 100 weight parts of film forming polymer.
    Type: Application
    Filed: September 14, 2010
    Publication date: November 15, 2012
    Inventors: Dominique Nicolas Cade, Xiongwei David He
  • Patent number: 8298595
    Abstract: A contact lens (4) comprises a solid component capable of imparting shape and structure to said lens, and a liquid component, at least partially contained in the solid component, capable of favoring the compatibility between said lens and the eye of a user of said lens, wherein the liquid component comprises a solution capable of being used as a lachrymal substitute.
    Type: Grant
    Filed: February 8, 2010
    Date of Patent: October 30, 2012
    Assignee: Safilens S.r.l.
    Inventor: Alessandro Filippo
  • Publication number: 20120269862
    Abstract: An ophthalmic composition is disclosed having a viscosity enhancement system comprised of two different viscosity enhancing agents. The aqueous composition contains a first viscosity enhancing agent that provides enhanced viscosity upon dispensing of the composition to the eye and a second viscosity agent that increases viscosity (e.g., gels or partially gels) after dispensing of the composition to the eye to provide extended viscosity enhancement of the composition.
    Type: Application
    Filed: April 19, 2012
    Publication date: October 25, 2012
    Inventors: Masood A. Chowhan, Malay Ghosh
  • Publication number: 20120270933
    Abstract: The present invention relates to compositions and methods for liquid statin products suitable for use in a person or animal. The invention provides stable liquid formulations containing a statin and at least one solubilizer. Methods for the oral administration of statin formulations are also provided by the invention.
    Type: Application
    Filed: June 29, 2012
    Publication date: October 25, 2012
    Applicant: MADEIRA THERAPEUTICS
    Inventors: Ken Phelps, Jabar Qasem, Lynn Gold
  • Publication number: 20120269908
    Abstract: The present invention relates to a carrier in oil-in-water emulsion form, containing a very small amount of a surface-active agent so that the emulsion is stable, well-tolerated, and nonirritating. The present invention also relates to a method for preparing a carrier according to the invention and to the use of such a carrier as a base for compositions to be applied onto sensitive human or animal body tissue, particularly in dermatological or dermocosmetic compositions.
    Type: Application
    Filed: November 27, 2009
    Publication date: October 25, 2012
    Applicant: OCTALIA TECHNOLOGIES
    Inventors: Christian Sarrazin, Marina Do, Michele Boix
  • Publication number: 20120264742
    Abstract: A pharmaceutical composition for external use which is an organogel containing a fatty acid ester and a glycerolglycerin fatty acid ester, in particular, a novel transdermally absorbable pharmaceutical composition for external use which has a drug such as non-narcotic analgesics as an active ingredient made in organogel form containing a drug such as non-narcotic analgesics as an active ingredient, a fatty acid ester and a glycerolglycerin fatty acid ester, and a method for producing the composition. The pharmaceutical composition significantly improves skin permeability of drugs such as non-narcotic analgesics and allows a sufficient amount of drug to permeate the skin sustainably. Moreover, since the pharmaceutical composition is in organogel form, it can be easily applied to a preparation in practice. In addition, the pharmaceutical composition can provide efficient use and the like of drugs due to a high drug release rate and therefore is highly useful.
    Type: Application
    Filed: November 11, 2010
    Publication date: October 18, 2012
    Applicants: NIPPON ZOKI PHARMACEUTICAL CO., LTD., NIHON UNIVERSITY
    Inventors: Takayuki Furuishi, Kazuo Tomono, Toyofumi Suzuki, Toshiro Fukami, Koji Kunimasu
  • Patent number: 8278438
    Abstract: The production of a diutan polysaccharide exhibiting increased viscosity properties as compared with previously produced polysaccharide of the same type of repeating units. Such an improved diutan polysaccharide is produced through the generation of a derivative of Sphingomonas sp. ATCC 53159 that harbors a multicopy broad-host-range plasmid into which genes for biosynthesis of diutan polysaccharide have been cloned. The plasmid provides the capability within the host Sphingomonas strain to produce multiple copies of genes for such polysaccharide synthesis. In such a manner, a method of not just increased production of the target diutan polysaccharide, but also production of a diutan polysaccharide of improved physical properties (of the aforementioned higher viscosity) thereof is provided. Such a diutan polysaccharide has proven particularly useful as a possible viscosifier in oilfield applications and within cement materials.
    Type: Grant
    Filed: September 28, 2010
    Date of Patent: October 2, 2012
    Assignee: CP Kelco U.S., Inc.
    Inventors: Nancy E. Harding, Yamini N. Patel, Russell Coleman, Steven Matzke
  • Publication number: 20120201891
    Abstract: A composition suitable for use in a transdermal delivery patch for administration of a biologically active compound, the composition comprising a phosphate compound of tocopherol and a polymer carrier.
    Type: Application
    Filed: March 30, 2011
    Publication date: August 9, 2012
    Inventors: Jeremy Cottrell, Giacinto Gaetano, Mahmoud El-Tamimy, Nicholas Kennedy, Paul David Gavin
  • Patent number: 8231896
    Abstract: A non-gelatin encapsulation system for liquid filled soft capsules, by nature of the carrier, the cationic-ionic balance of the carrier and the active ingredients, or the concentration of the active ingredients and excipients, are difficult or impossible to commercially encapsulate in gelatin capsules. In particular, the system is adapted for the encapsulation of highly basic, or alkaline, fills. The system provides for a predominantly starch and gelling carrageenan based shell, which displays high resistance to both concentrated fills and to alkaline fills, in particular, to those fills which contain the salt or salts of weak acids and strong bases.
    Type: Grant
    Filed: November 8, 2004
    Date of Patent: July 31, 2012
    Assignee: R.P. Scherer Technologies, LLC
    Inventors: Keith E. Tanner, Rickey S. Shelley, Norman S. Stroud, Elizabeth Youngblood
  • Publication number: 20120171270
    Abstract: The present invention discloses systems and methods for controlling arthropod populations. The systems include a polymeric substrate, a semiochemical that is reactive upon an adult-stage arthropod, and an insecticide that is toxic to an immature-stage arthropod. The semiochemical may be a sex pheromone that disrupts mating behavior of the adult-stage arthropod. The insecticide may be a per os insecticide that only affects the immature-stage arthropod. The arthropod to be controlled may be gypsy moths, in which case the semiochemical may be disparlure and the insecticide may be spinosad. Further disclosed are methods for preparing systems for use in controlling arthropod populations.
    Type: Application
    Filed: December 29, 2010
    Publication date: July 5, 2012
    Inventor: Agenor Mafra-Neto
  • Publication number: 20120128731
    Abstract: The invention provides a biocompatible carrier and method for fabricating the same. The biocompatible carrier includes: a gel, and a plurality of metal nanoparticles, an organic compound or combinations thereof embedded in the gel, wherein the metal nanoparticles, the organic compound or combinations thereof are uniformly distributed in the gel.
    Type: Application
    Filed: March 29, 2011
    Publication date: May 24, 2012
    Applicant: NATIONAL SUN YAT-SEN UNIVERSITY
    Inventor: Shu-Chen Hsieh
  • Publication number: 20120058165
    Abstract: A lotion for opacifying a wet wipe. A wet wipe may comprise a lotion, the lotion comprising an opacifying agent. The lotion or the substrate may further comprise a retention aid. The substrate may comprise an opacifying agent the same as or different than the opacifying agent of the lotion. A method for opacifying a wet wipe by loading onto a wipe substrate a lotion comprising an opacifying agent. A method for aesthetically modifying a wet wipe by selectively loading onto a wipe substrate a lotion comprising an opacifying agent.
    Type: Application
    Filed: August 30, 2011
    Publication date: March 8, 2012
    Inventors: Thomas James Klofta, Kristin Hofmann Miller, Christoph Hans Peter Bonauer, Samir M. Aziz, Astrid Annette Sheehan
  • Patent number: 8088205
    Abstract: The invention relates to a wood preservative, which wood preservative contains vegetable oils processed from crude tall oil, such as resin acids and fatty acids. The wood preservative according to the invention is characterized by that the wood preservative is crude tall oil, from which have been removed neutral components contained by the crude tall oil, especially compounds acting as the breeding ground and nutriment of rot fungi and/or compounds causing esterification reactions, such as fatty alcohols and/or steroid groups, such as sitosterol and sitostanol. The invention also relates to a method for manufacturing wood preservative according to the invention.
    Type: Grant
    Filed: August 7, 2007
    Date of Patent: January 3, 2012
    Assignee: Holjakka Oy
    Inventor: Hannu Boren
  • Patent number: 8052990
    Abstract: The invention relates to a method for producing a biocompatible crosslinked gel consisting in crosslinking a determined quantity of at least one type of liquid biocompatible polymer by adding a quantity of crosslinking agent, in carrying out a crosslinking reaction, in adding an additional quantity of liquid polymer whose molecular mass is greater than 500,000 Da, in solving the reaction mixture in such a way that the total concentration of the liquid polymer is reduced, in crosslinking and in stopping the crosslinking reaction by removing the crosslinking agent. The inventive gel and the use thereof are also disclosed.
    Type: Grant
    Filed: January 31, 2005
    Date of Patent: November 8, 2011
    Assignee: Anteis S.A.
    Inventors: Laurence Hermitte, Olivier Benoit
  • Publication number: 20110237623
    Abstract: A sustained-release formulation for an acetylcholinesterase inhibitor, comprising an acetylcholinesterase inhibitor and at least two gel-forming polymers, and methods of manufacture thereof. The acetylcholinesterase inhibitor preferably comprises donepezil.
    Type: Application
    Filed: February 28, 2011
    Publication date: September 29, 2011
    Inventors: Adel Penhasi, Mila Gomberg